Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
N
Shared by NobleBlocks on May 1, 2021 • 12:00 AM UTC
Authors:
Xenofon Baraliakos
,
Laure Gossec
,
Effie Pournara
Research Assistant
AI chat, annotations, notes & similar papers
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial | NobleBlocks
